Global  

First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response

Science Daily Friday, 22 May 2020 ()
A study of 108 adults finds that the vaccine produced neutralizing antibodies and T-cell response against SARS-CoV-2, but further research is needed to confirm whether the vaccine protects against SARS-COV-2 infection.
0
shares
ShareTweetSavePostSend
 
Credit: Wochit - Published
News video: Coronavirus Vaccine From China Is Safe In Early Trial

Coronavirus Vaccine From China Is Safe In Early Trial 00:40

A coronavirus vaccine developed by CanSino Biologics Inc appears to be safe. It induced a rapid immune response in its first human trial, Reuters reports. This vaccine did not cause any serious adverse effects, though side effects such as fever were noted. Blood samples from the 108 vaccinated...

You Might Like


Related videos from verified sources

Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine [Video]

Dr. Fauci Is 'Cautiously Optimistic' About Possibility Of COVID-19 Vaccine

Researchers working on a vaccine for the novel coronavirus have announced promising results in a very small drug trial. Biotech company Moderna said the first phase of trials for a COVID-19 vaccine..

Credit: Wochit     Duration: 00:32Published
Ask Dr. Nandi: Moderna’s coronavirus vaccine shows encouraging early results in human safety trial [Video]

Ask Dr. Nandi: Moderna’s coronavirus vaccine shows encouraging early results in human safety trial

There’s some positive news concerning an experimental vaccine for the coronavirus. Drugmaker Moderna has announced that all of their participants in a stage 1 trial produced antibodies for COVID-19..

Credit: WXYZ Detroit     Duration: 03:19Published

Tweets about this